Tags: Press release


Cambrex Completes Large-Scale US API Expansion

Cambrex announced today the completion of a $50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing capabilities at its Charles City, Iowa facility. The startup of the new manufacturing space is the culmination of a two-year project, originally announced in 2020, to increase the capacity of Cambrex’s flagship API facility by 30%.

April 12, 2022

Pilot Chemical Becomes Exclusive Marketer of Integrity Bio-Chemicals’ Sustainable, High-Performance Biosurfactants in North American Markets

Pilot Chemical Corp. today announced an agreement with Integrity Bio-Chemicals (IBC) to be the exclusive marketer of IBC’s Tegrasurf TM line of high-performance biosurfactants into the North American Household, Industrial & Institutional (HI&I) markets. Tegrasurf TM products offer a substantial reduction in carbon footprint relative to many conventional surfactants while also exhibiting superior performance in foam stability and surface tension reduction.

April 4, 2022





Cambrex Expands Biopharmaceutical Services Business

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced it is significantly expanding its existing biopharmaceutical testing services business.

March 1, 2022

MFG Chemical Hires Katy Zukis Business Development Manager

MFG Chemical, a global leader in specialty and custom chemical manufacturing, announces the hiring of Katy Zukis, Business Development Manager.  In addition to driving top line sales growth, Katy will be shaping MFG Chemical’s Oil and Gas SBU strategy, optimizing the product portfolio and developing a robust pipeline. Katy will work out of MFG Chemical’s sales office in Houston.

February 21, 2022